Severe gastrointestinal toxicity of MEK inhibitors

Mourad, N; Lourenco, N; Delyon, J; Eftekhari, P; Bertheau, P; Allayous, C; Ballon, A; Pages, C; Allez, M; Lebbe, C; Baroudjian, B

Mourad, N (reprint author), Hop St Louis, Oncodermatol Unit, Dept Dermatol, 1 Ave Claude Vellefaux, F-75010 Paris, France.

MELANOMA RESEARCH, 2019; 29 (5): 556

Abstract

Gastrointestinal toxicities of MEK inhibitors in melanoma patients are frequent. In clinical trials, the most common digestive adverse events were nau......

Full Text Link